ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 51 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $253,592 | +94.8% | 272,681 | +205.8% | 0.00% | – |
| Q4 2022 | $130,190 | -93.9% | 89,171 | -84.3% | 0.00% | -100.0% |
| Q4 2021 | $2,130,000 | -73.5% | 567,796 | -63.5% | 0.00% | -87.9% |
| Q3 2021 | $8,033,000 | +113.2% | 1,553,800 | +312.9% | 0.03% | +26.9% |
| Q2 2020 | $3,768,000 | +10665.7% | 376,340 | +1193.2% | 0.03% | – |
| Q4 2019 | $35,000 | -70.8% | 29,102 | -63.3% | 0.00% | -100.0% |
| Q3 2019 | $120,000 | -84.0% | 79,248 | -39.1% | 0.00% | -87.5% |
| Q4 2018 | $748,000 | -56.0% | 130,050 | -7.8% | 0.01% | -50.0% |
| Q4 2015 | $1,700,000 | – | 140,983 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |